Medpace
MEDP
$386.34
Share price
0.17%
Change (1 day)
86.74%
Change (1 year)
Categories
Medpace (MEDP) - P/B ratio
P/B ratio as of June 2024 : 17.9
According to Medpace's latest financial reports the company has a price-to-book ratio of 17.9.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Medpace - P/B ratio (from 2016 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | 16.8 | -1.58% |
| 2022-12-31 | 17.1 | 108.29% |
| 2021-12-31 | 8.21 | 32.83% |
| 2020-12-31 | 6.18 | 48.04% |
| 2019-12-31 | 4.17 | 30.39% |
| 2018-12-31 | 3.20 | 25.47% |
| 2017-12-31 | 2.55 | 6.08% |
| 2016-12-31 | 2.41 | |
| 2015-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 1.83 | -89.76% | 🇺🇸 USA |